Table 6.
Discriminatory performance of risk stratification scores within validation cohort (complete case) to predict in-hospital mortality in patients with covid-19
| Model | Validation cohort* | |
|---|---|---|
| No of patients with required parameters | AUROC (95% CI) | |
| SOFA | 197 | 0.614 (0.530 to 0.698) |
| qSOFA | 19 361 | 0.622 (0.615 to 0.630) |
| Surgisphere† | 18 986 | 0.630 (0.622 to 0.639) |
| SMARTCOP | 486 | 0.645 (0.593 to 0.697) |
| NEWS | 19 074 | 0.654 (0.645 to 0.662) |
| DL score† | 16 345 | 0.669 (0.660 to 0.678) |
| SCAP | 370 | 0.675 (0.620 to 0.729) |
| CRB65 | 19 361 | 0.683 (0.676 to 0.691) |
| COVID-GRAM† | 1239 | 0.706 (0.675 to 0.736) |
| DS-CRB65 | 18 718 | 0.718 (0.710 to 0.725) |
| CURB65 | 15 560 | 0.720 (0.713 to 0.728) |
| Xie score† | 1753 | 0.727 (0.701 to 0.753) |
| A-DROP | 15 572 | 0.736 (0.728 to 0.744) |
| PSI | 360 | 0.736 (0.683 to 0.790) |
| E-CURB65 | 1553 | 0.764 (0.740 to 0.788) |
| 4C Mortality Score | 14 398 | 0.774 (0.767 to 0.782) |
AUROC=area under the receiver operating characteristic curve; covid-19=coronavirus disease 2019.
See appendix 13 for other metrics.
*
Available data.
†
Novel covid-19 risk stratification score.